Severity of erectile dysfunction in married impotent patients: Interrelationship with anthropometry, hormones, metabolic profiles and lifestyle

International Journal of Urology

Volumn 14, Issue 1, 2007, Pages 48-53

  Paick, Jae Seung ^a   Yang, Ji Hyun ^a   Kim, Soo Woong ^a   Ku, Ja Hyeon ^b  

^a Seoul National University   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

Body mass index; Cardiovascular disease; Erectile dysfunction; Metabolic syndrome; Testosterone

Indexed keywords

PROLACTIN; TESTOSTERONE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; IMPOTENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIED MAN; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTHROPOMETRY; HUMANS; IMPOTENCE; LIFE STYLE; MALE; MIDDLE AGED; PROLACTIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 33845650735     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01661.x     Document Type: Article

References (36)

1. Feldman HA, Johannes CB, Derby CA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev. Med. 2000; 30: 328-38.
2. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251-3.
3. Virag R, Bouily P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181-4.
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97.
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
6. Esposito K, Giugliano F, Martedi E et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005; 28: 1201-3.
7. Matfin G, Jawa A, Fonseca VA. Erectile dysfunction: interrelationship with the metabolic syndrome. Curr. Diab. Rep. 2005; 5: 64-9.
8. Celermajer DS, Sorensen KE, Bull. C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 1994; 24: 1468-74.
9. Shiwaku K, Nogi A, Kitajima K et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J. Occup. Health 2005; 47: 126-35.
10. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004; 27: 2027-32.
11. Marumo K, Nakashima J, Murai M. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int. J. Urol. 2001; 8: 53-9.
12. Anuurad E, Shiwaku K, Nogi A et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J. Occup. Health 2003; 45: 335-43.
13. Chung TG, Lee TK, Chung S et al. The Korean version of the International Index of Erectile Function (IIEF): reliability and validation study. Korean J. Urol. 1999; 40: 1334-43.
14. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346-51.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
16. Aversa A, Isidori AM, De Martino MU et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin. Endocrinol. 2000; 53: 517-22.
17. Jain P, Rademaker AW, McVary KT. Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J. Urol. 2000; 164: 371-5.
18. Kratzik CW, Schatzl G, Lunglmayr G, Rucklinger E, Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J. Urol. 2005; 174: 240-3.
19. Gooren LJ. Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch. Sex. Behav. 1987; 16: 463-73.
20. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann. Intern. Med. 2003; 139: 161-8.
21. Schiavi RC, Stimmel BB, Mandeli J, White D. Chronic alcoholism and male sexual function. Am. J. Psychiatry 1995; 152: 1045-51.
22. National Institute of Health. Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Excutive Summary. Bethesda, MD, National Institute of Health, National Heart, Lung and Blood Institute, 2001.
23. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302-6.
24. Walczak MK, Lokhandwala N, Hodge MB, Guay AT. Prevalence of cardiovascular risk factors in erectile dysfunction. J. Gend. Specif. Med. 2002; 5: 19-24.
25. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J. Clin. Endocrinol. Metab. 1994; 79: 997-1000.
26. Zumoff B, Strain GW, Miller LK et al. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 1990; 71: 929-31.
27. Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr. Metab. Cardiovasc. Dis. 2004; 14: 228-32.
28. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and - independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J. Am. Coll. Cardiol. 2004; 43: 179-84.
29. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med. Hypotheses 2001; 56: 702-8.
30. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001; 85: 342-50.
31. Whaercroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet. Med. 2003; 20: 255-68.
32. Schachter M. Erectile dysfunction and lipid disorders. Curr. Med. Res. Opin. 2000; 16 (Suppl. 1): s9-12.
33. Lim TO, Das A, Rampal S et al. Cross-cultural adaptation and validation of the English version of the International Index of Erectile Function (IIEF) for use in Malaysia. Int. J. Impot. Res. 2003; 15: 329-36.
34. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J. Clin. Hypertens. 2006; 8: 359-64.
35. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs 2005; 65: 773-86.
36. Tsujimura A, Matsumiya K, Matsuoka Y et al. Bioavailable testosterone with age and erectile dysfunction. J. Urol. 2003; 170: 2345-7.